Fonar returns to profitability in third quarter
MRI vendor Fonar is back in the black for the first time sinceMarch 1994. The Melville, NY, company posted financial resultsfor its third fiscal quarter (end-March) that show net incomeof $1.9 million, compared with a net loss of $903,000 in the
MRI vendor Fonar is back in the black for the first time sinceMarch 1994. The Melville, NY, company posted financial resultsfor its third fiscal quarter (end-March) that show net incomeof $1.9 million, compared with a net loss of $903,000 in the sameperiod last year. The growth in profits came as Fonar's revenuesslipped to $3 million in the most recent quarter, compared with$3.2 million in the third quarter of 1995.
Fonar did not indicate how it was able to record such a rapidprofit turnaround on lower sales. It is possible that the companyis enjoying the benefits of payments related to MRI patent litigationit has settled with Hitachi and Philips, but Fonar declined tostate whether it received any such payments in its most recentquarter.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.
